#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression
Click to read this study in The Lancet Oncology.
Click to read this study in The Lancet Oncology.
Click to read this study in JAMA Network Open.
Click to read this study in the European Journal of Cancer.
Click to read this study in the Journal of Clinical Oncology.
Click to read the study in the Journal of Clinical Oncology.
1. Patients with peripheral artery disease who received a drug-coated device did not face an increased risk of death compared ...
1. Patients with peripheral artery disease who received a drug-coated device did not face an increased risk of death compared ...
Click to read the study in JAMA Network Open
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.